8th May 2013

The BMJ is urging the European Medicines Agency to press on with bold plans to prospectively release anonymised clinical trial data on drugs. You can read the full article here (£). This response comes after the EU General Court decision to order the European Medicines Agency not to release Clinical Study Reports submitted by companies as part of marketing authorisation for medicines. This ruling was made as part of court cases brought by two pharmaceutical companies, AbbVie and InterMune, who challenged the Agency’s decisions to grant access to the information.